ANGIOMATOID FIBROUS HISTIOCYTOMA

Clinical trials for ANGIOMATOID FIBROUS HISTIOCYTOMA explained in plain language.

Never miss a new study

Get alerted when new ANGIOMATOID FIBROUS HISTIOCYTOMA trials appear

Sign up with your email to follow new studies for ANGIOMATOID FIBROUS HISTIOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for tough sarcomas: adding a targeted drug to standard treatment

Disease control Ongoing

This study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…

Matched conditions: ANGIOMATOID FIBROUS HISTIOCYTOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

ANGIOMATOID FIBROUS HISTIOCYTOMA

Get alerted when new ANGIOMATOID FIBROUS HISTIOCYTOMA trials appear

New hope for tough sarcomas: adding a targeted drug to standard treatment